Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activins and activin antagonists in hepatocellular carcinoma.
Deli A, Kreidl E, Santifaller S, Trotter B, Seir K, Berger W, Schulte-Hermann R, Rodgarkia-Dara C, Grusch M. Deli A, et al. Among authors: rodgarkia dara c. World J Gastroenterol. 2008 Mar 21;14(11):1699-709. doi: 10.3748/wjg.14.1699. World J Gastroenterol. 2008. PMID: 18350601 Free PMC article. Review.
The activin axis in liver biology and disease.
Rodgarkia-Dara C, Vejda S, Erlach N, Losert A, Bursch W, Berger W, Schulte-Hermann R, Grusch M. Rodgarkia-Dara C, et al. Mutat Res. 2006 Nov-Dec;613(2-3):123-37. doi: 10.1016/j.mrrev.2006.07.002. Epub 2006 Sep 25. Mutat Res. 2006. PMID: 16997617 Review.
Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.
Gauglhofer C, Sagmeister S, Schrottmaier W, Fischer C, Rodgarkia-Dara C, Mohr T, Stättner S, Bichler C, Kandioler D, Wrba F, Schulte-Hermann R, Holzmann K, Grusch M, Marian B, Berger W, Grasl-Kraupp B. Gauglhofer C, et al. Among authors: rodgarkia dara c. Hepatology. 2011 Mar;53(3):854-64. doi: 10.1002/hep.24099. Epub 2011 Feb 11. Hepatology. 2011. PMID: 21319186
NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
Macheiner D, Gauglhofer C, Rodgarkia-Dara C, Grusch M, Brachner A, Bichler C, Kandioler D, Sutterlüty H, Mikulits W, Schulte-Hermann R, Grasl-Kraupp B. Macheiner D, et al. Among authors: rodgarkia dara c. Cancer Res. 2009 Jan 1;69(1):235-42. doi: 10.1158/0008-5472.CAN-08-2144. Cancer Res. 2009. PMID: 19118008
Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients.
Sonnleitner ST, Prelog M, Jansen B, Rodgarkia-Dara C, Gietl S, Schönegger CM, Koblmüller S, Sturmbauer C, Posch W, Almanzar G, Jury H, Loney T, Tichy A, Nowotny N, Walder G. Sonnleitner ST, et al. Among authors: rodgarkia dara c. Transbound Emerg Dis. 2022 May;69(3):1596-1605. doi: 10.1111/tbed.14130. Epub 2021 May 27. Transbound Emerg Dis. 2022. PMID: 33960696 Free PMC article.